[1] YOU T G, WANG H S, YANG J H. Transfection of IL-2 and/or IL-12 genes into spleen in treatment of rat liver cancer. World J Gastroenterology2004(15)
[2] KUSHIDA S, PENG B G, UCHIMURA E. A tumour vaccine of fixed tumour fragments in a controlled-release vehicle with cytokines for therapy of hepatoma in mice, 2004(7)
[3] ITOKAWA Y, MAZDA O, UEDA Y. Interleukin-12 genetic administration suppressed metastatic liver tumor unsusceptible to CTL. 2004(4). doi:10.1016/j.bbrc.2003.12.200
[4] JAIN A, SLANSKY J E, MATEY L C. Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases. 2003
[5] MATSUI M, MSCHIDA S, ITANI-YOHDA T. Downregulation of the proteasome submits,transporter and antigen presentation in hipatocellular carcinoma,and their restoration by in terferon-gamma, 2002(8)
[6] CHOI E A, LEI H, MARON D J. Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastases. 2004(4). doi:10.1158/1078-0432.CCR-0040-03
[7] YOON S K, KIM T G, CHO H I. Suppression of tumor formation and indution of natural killer cell activity in BALB/c nude mice by human B7-1(CD80) gene transfer subcutaneously injected with human hepatocellular carcinoma cells(Huh-7), 2003
[8] GE N L, YE S L, ZHENG N. Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines. World J Gastroenterology2003(10)
[9] PAN P Y, LI Y, LI Q. In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery. 2004(1)
[10] BRISTOL J A, ZHU M, JI H. In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF. 2003(6)
[11] IRIE M, HOMMA S, KOMITA H. Inhibition of spontaneous development of liver tumors by inoculation with dendritic cells loaded with hepatocellular carcinoma cells in C3H/HeNCRJ mice. 2004(2)
[12] CHAN R C, XIE H, ZHAO G P. Dendritomas formed by fusion of mature dendritic cells with allogenic human hepatocellular carcinoma cells activate autologous cytotoxic T lymphocytes. 2002(3). doi:10.1016/S0165-2478(2)00078-0
[13] HIRAMOTO J S, TSUNG K, BEDOLLI M. Antitumor immunity induced by dendritic cell-based vaccination is dependent on interferon-gamma and interleukin-12. 2004(1)
[14] IWASHITA Y, TAHARA K, GOTO S. Aphase I study of autologous dendritic cell-based immunotherpy for patients with unresectable primary liver cancer, 2003(3)
[15] TATSUMI T, TAKENHARA T, KANTO T. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma. 2001(20)
[16] LU S Y, SUI Y F, LI Z S. Superantigen-SEA gene modified tumor vaccine for hepatocellular carcinoma:an in vitro study. World J Gastroenterology2004(1)
[17] PENG B G, LIU S Q, KUANG M. Autologous fixed tumor vaccine:a formulation with cytokine-microparticles for protective immunity against recurrence of human hepatocellular carcinoma. 2002(4)
[18] LU J, LENG X, PENG J. Induction of cytotoxic T lymphocytes from the peripheral blood of a hepatocellular carcinoma patient using melanoma antigen-1(MAGE-1) peptide. Chin Med J2002(7)
[19] MENG W S, BUTTERFIELD L H, RIBAS A. Alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination. 2001(24)
[20] FORGUES M, DIFILIPPANTONIO M J, LINKE S P. Involvement of Crml in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles. 2003(15). doi:10.1128/MCB.23.15.5282-5292.2003
[21] CHUN E, LEE J, CHEONG H. Tumor eradication by hepatitis B virus x antigen-specific CD8+T cells in xenografted nude mice. 2003(3)
[22] WANG F S, LIU M X, ZHANG B. Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo. World J Gastroenterology2002(3)
[23] SAWAYAMA T, SAKAGUCHI K, SENOH T. Effects of pulsing procedure of IL-12 in combination with IL-2 on the activation of peripheral blood lymphocytes derived from patients with hepatocellular carcinoma, 2003(6) |
